WASHINGTON DC, Sept. 19, 2008 -- The US
Food and Drug Administration (FDA) has responded to a public advisory
panel of outside experts who listened to patient experiences with
LASIK and considered how to improve information for patients and
physicians about LASIK.
In response to the feedback from the public and LASIK
experts, the FDA has implemented several improvements in
communications with the public regarding LASIK-related safety
issues.
Improvements include updating the FDA's Lasik website to make
it easier to report a Lasik problem to MedWatch, the
government's system to receive complaints relating to FDA
approved medical devices. Updated public information includes an emphasis that halos, glare,
night vision problems and dry eye from Lasik should be reported
to FDA.
A patient information card is being designed with cooperation
of the American
Academy of Ophthalmology that physicians can fill out with the
patient’s eye measurements before their LASIK surgery. Patients
can keep this card to help their doctor calculate the lens
implant power should they need to have future cataract surgery.
Source
FDA
